Recent scrutiny has forced the issue of congressional stock trading into the limelight.
The potential conflict of interest is blatantly obvious. Lawmakers should focus on the most efficient legislation and not what might best serve their financial interests. Sure, some laws achieve both, but voters shouldn t have to worry if their Washington representatives stock portfolios would benefit from, or influence directly, their decisions as lawmakers.
A lawmaker who owns shares in America s big banks might have different views on banking deregulation, for example, said James Cox, professor of corporate and securities law at Duke University. We should be very concerned about the fact that if you re able to profit on individual stocks, it may impact the kind of decisions you ll make for your activities as a Senator, said Cox.
Health
your username
December 10, 2020
In the Eastern District of California on Wednesday, Antech Diagnostics Inc. and Dr. Christian Leutenegger filed a complaint against Idexx Laboratories Inc., seeking declaratory relief related to threatened litigation by Idexx over trade secrets and Leutenegger’s contract with Idexx, his former employer.
Leutenegger, a veterinary scientist who develops “quantitative polymerase chain reaction (qPCR or real-time PCR) tests” that primarily can detect and measure infections in animals, joined Idexx in 2006 after postdoctoral work at the University of California-Davis. According to the complaint, he “helped pioneer the use of qPCR tests for diagnostic purposes in veterinary medicine.”